The weekly litigation news digest is live. Subscribe now

IP Verse

Non-Diffusive Botulinum Toxin Causing Local Muscle Paralysis, And Purification Method Thereof - EP2578228

The patent EP2578228 was granted to Medexgen on Nov 15, 2017. The application was filed on May 13, 2011 under application number EP11789976A. The patent is currently recorded with a legal status of "Revoked".

EP2578228

MEDEXGEN
Application Number
EP11789976A
Filing Date
May 13, 2011
Status
Revoked
May 13, 2022
Publication Date
Nov 15, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIGAug 14, 2018SCHIENER -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONKR20020000685
DESCRIPTIONKR20080016800
DESCRIPTIONUS7354740
DESCRIPTIONUS7452697
EXAMINATIONUS2005238664
INTERNATIONAL-SEARCH-REPORTKR20030060150
INTERNATIONAL-SEARCH-REPORTKR20050074806
INTERNATIONAL-SEARCH-REPORTKR20090091501
OPPOSITIONKR20050074806
OPPOSITIONWO2011152618
OTHERUS2005238664

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents